Compound ID | 1452

Update compound information

Isoniazid

Class: Cell-wall synthesis inhibitor

Spectrum of activity: Gram-negative
Details of activity: Gram Negative bacilli
Institute where first reported: CMP Pharma Inc
Year first mentioned: 1952
Highest developmental phase: Approved by FDA in 1983
Development status: Approved
Reason Dropped: Other formulations were discontinued
Chemical structure(s):
Click here for structure editor
Molecular weight: 137.14
Iso. SMILES: C1=CN=CC=C1C(=O)NN
InChI Key: QRXWMOHMRWLFEY-UHFFFAOYSA-N
Can. SMILES: C1=C(C=CN=C1)C(=O)NN
InChI: InChI=1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10)
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/3767
Guide to Pharmacology: isoniazid
Citations:
  • https://pubmed.ncbi.nlm.nih.gov/14903503/
  • https://science.sciencemag.org/content/116/3006/129?ijkey=ce98bdac10b3ec52eb42daf76249fa3d06894de3&keytype2=tf_ipsecsha
  • https://aac.asm.org/content/64/2/e01899-19

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.